Hosted by Medicenna Therapeutics and IMadeIt.ai, London Calling: Medicenna’s Biotech Milestones brought together leaders in biotech, healthcare, academia, and investment alongside top-performing high school students to celebrate innovation, collaboration, and the future of Canadian scienc —an event that will now be held annually
“I’m excited to be able to highlight the success of Canadian biotech, especially in light of Medicenna’s recent achievements and potential to transform the lives of patients. And London is a place close to my heart given it’s foundational impact on my journey in the biomedical field.”
President, CEO of Medicenna Therapeutics
From Hospitals, Big Pharma, Biotech, Academia, and Investment
Actively engaged in real-world co-op projects through IMadeIt.ai
Professor of Neurosurgery at Duke University
Research Lecturer at the University of Oxford, RDM
Founder and CEO of Deep Breathe
Chair of Infectious Diseases, Schulich School of Medicine & Dentistry at Western University
Co-founder of BLES Biochemicals Inc.
CEO of Launchit Solutions
Executive, Advisor, Board Member - Medtech and Life Sciences
Clinical Research Manager at Robarts Research Institute
Chairman of Turnium Technology Group Inc.
Youth in Action
At the London Calling event, students gained firsthand exposure to Canada’s biotech industry, connected with CEOs, researchers, and investors, toured cutting-edge labs, and participated in high-level discussions—empowering them with real-world insights, professional inspiration, and a clearer vision for their future careers in science, business, and innovation.
“I’m excited to be able to highlight the success of Canadian biotech, especially in light of Medicenna’s recent achievements and potential to transform the lives of patients. And London is a place close to my heart given it’s foundational impact on my journey in the biomedical field.”
Co-op by IMadeIt.ai
“I’m excited to be able to highlight the success of Canadian biotech, especially in light of Medicenna’s recent achievements and potential to transform the lives of patients. And London is a place close to my heart given it’s foundational impact on my journey in the biomedical field.”
Co-op by IMadeIt.ai
